AI in Drug Discovery: 2025 Outlook | Foley & Lardner LLP
Given this highly dynamic landscape, the AI drug discovery sector will require commensurate innovation in legal/riskmanagement frameworks to ensure …
Read the original at Foley & Lardner LLP ↗
- Topics
- Governance & Risk ManagementLegal & Courts
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”